Verrica Pharmaceuticals Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Verrica Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Verrica Pharmaceuticals Inc. Return On Equity for the quarter ending September 30, 2024 was 1.3K %.
  • Verrica Pharmaceuticals Inc. annual Return On Equity for 2023 was -147 %, a 89.9% decline from 2022.
  • Verrica Pharmaceuticals Inc. annual Return On Equity for 2022 was -77.4 %, a 3.38% decline from 2021.
  • Verrica Pharmaceuticals Inc. annual Return On Equity for 2021 was -74.9 %, a 22.3% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -147 -69.6 -89.9% Jan 1, 2023 Dec 31, 2023
2022 -77.4 -2.53 -3.38% Jan 1, 2022 Dec 31, 2022
2021 -74.9 +21.5 +22.3% Jan 1, 2021 Dec 31, 2021
2020 -96.4 -58.3 -153% Jan 1, 2020 Dec 31, 2020
2019 -38.1 -8.44 -28.5% Jan 1, 2019 Dec 31, 2019
2018 -29.6 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.